<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: A <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis provokes significant levels of <z:e sem="disease" ids="C0700361" disease_type="Mental or Behavioral Dysfunction" abbrv="">emotional distress</z:e>, with <z:e sem="disease" ids="C0558066" disease_type="Mental or Behavioral Dysfunction" abbrv="">intrusive thoughts</z:e> being the most common manifestation among <z:hpo ids='HP_0003002'>breast cancer</z:hpo> survivors </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e>-related <z:e sem="disease" ids="C0558066" disease_type="Mental or Behavioral Dysfunction" abbrv="">intrusive thoughts</z:e> can take the form of emotional memories, flashbacks, nightmares, and intrusive images </plain></SENT>
<SENT sid="2" pm="."><plain>Emotional arousal after a severe life stressor prolongs adrenergic activation, which in turn may increase risk for post-traumatic symptomatology </plain></SENT>
<SENT sid="3" pm="."><plain>However, <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> beta-blockers block adrenergic activation and are known to reduce traumatic memories and related <z:e sem="disease" ids="C0815107" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychological distress</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, the current study examined the association between beta-blocker use and the severity of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:e sem="disease" ids="C0558066" disease_type="Mental or Behavioral Dysfunction" abbrv="">intrusive thoughts</z:e> and related symptoms following a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: The 174 breast and 36 female <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients who had recently undergone diagnostic screening or biopsy included 39 beta-blocker users and 171 non-users </plain></SENT>
<SENT sid="6" pm="."><plain>Prior to any <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment including surgery, participants completed questionnaires that included the Impact of Events Scale and the Center for Epidemiological Studies <z:hpo ids='HP_0000716'>Depression</z:hpo> Scale </plain></SENT>
<SENT sid="7" pm="."><plain>Analyses controlled for age, education, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stage, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type, days since diagnosis, marital status, <z:hpo ids='HP_0000716'>depression</z:hpo>, and comorbidities </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Although the high rates of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related distress in this sample were similar to those of other studies with recently diagnosed patients, beta-blocker users endorsed 32% fewer <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:e sem="disease" ids="C0558066" disease_type="Mental or Behavioral Dysfunction" abbrv="">intrusive thoughts</z:e> than non-users </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Recently diagnosed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients using beta-blockers reported less <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:e sem="disease" ids="C0815107" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychological distress</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>These results suggest that beta-blocker use may benefit <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients' psychological adjustment following diagnosis, and provide a promising direction for future investigations on the pharmacological benefits of beta-blockers for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related distress </plain></SENT>
<SENT sid="11" pm="."><plain>Copyright Â© 2012 John Wiley &amp; Sons, Ltd </plain></SENT>
</text></document>